Core Insights - The company reported a total revenue of 357 million yuan in Q1 2025, representing a year-on-year growth of 10.01%, despite a net loss of 10.39 million yuan, indicating an improvement in profitability metrics [1] Financial Performance - The gross margin reached 30.04%, an increase of 17.66% year-on-year, while the net margin was -3.15%, reflecting a year-on-year increase of 70.32%, suggesting effective cost control and enhanced product value [2] Cost Control - Total selling, administrative, and financial expenses amounted to 48.81 million yuan, with the expense ratio decreasing from 16.91% to 13.69% year-on-year, a decline of 19.07%, indicating effective expense management [3] Cash Flow and Debt Management - Operating cash flow per share improved from -0.31 yuan to -0.11 yuan, a year-on-year increase of 65.58%, although it remains negative; cash and cash equivalents decreased by 7.73% to 798 million yuan, and accounts receivable fell by 13.20% to 1.741 billion yuan. Interest-bearing debt rose to 1.574 billion yuan, an increase of 2.94%, with a cash to current liabilities ratio of only 60.38%, highlighting ongoing cash flow and debt challenges [4] Business Model and Financing - The company's performance is primarily driven by research and development, with cumulative financing of 1.032 billion yuan and cumulative dividends of 422 million yuan since its listing, resulting in a dividend-to-financing ratio of 0.41, reflecting a balance between R&D investment and shareholder returns [5]